Menorrhagia Study in Women With Treatment-resistant Menorrhagia
NCT00288691
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Menorrhagia
Interventions
DRUG:
Asoprisnil (BAY86-5294)
DRUG:
Asoprisnil (BAY86-5294)
DRUG:
Asoprisnil (BAY86-5294)
DRUG:
Placebo
Sponsor
Bayer
Collaborators
[object Object]